Humana Inc vs Howmet Aerospace Inc — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Howmet Aerospace Inc trades at $223.4 (market cap $88.83B). The key difference: Howmet Aerospace Inc is the larger of the two by market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Howmet Aerospace Inc for 35 Days on average.
| HUM | HWM | |
|---|---|---|
Market Cap | $47.61B | $88.83B |
Volume | 1,827,332 | 2,587,589 |
Sector | Health | Industrials |
52-Week High | $409.85 | $292.65 |
52-Week Low | $163.67 | $184.09 |
Typical Hold Time | 53 Days | 35 Days |
Enterprise Value | $54.97B | $92.93B |
Dividend Yield | 0.89% | 0.25% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Howmet Aerospace (HWM) trades at $222.70, down 3.84% amid bearish technical signals, though fundamentals remain strong with consistent earnings beats and robust profitability. The stock shows solid revenue growth from $8.25B in 2025 to $9.1B projected for 2026, with net margins improving to 20.52%. Recent news highlights defense and aerospace demand drivers, while analyst consensus remains overwhelmingly bullish with an average price target of $328.10 representing 47% upside potential.
HWM presents a compelling growth story with strong fundamentals and analyst support, though technical weakness and high valuation multiples warrant caution. The primary investment thesis centers on continued aerospace sector strength and execution on growth initiatives, while risks include valuation compression and sector-specific headwinds. Current levels may offer entry points for long-term investors despite near-term technical pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →